BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21898348)

  • 1. Distinguishing the proapoptotic and antiresorptive functions of risedronate in murine osteoclasts: role of the Akt pathway and the ERK/Bim axis.
    Matsumoto T; Nagase Y; Iwasawa M; Yasui T; Masuda H; Kadono Y; Nakamura K; Tanaka S
    Arthritis Rheum; 2011 Dec; 63(12):3908-17. PubMed ID: 21898348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Ras/extracellular signal-regulated kinase, but not Akt pathway in risedronate-induced apoptosis of U937 cells and its suppression by cytochalasin B.
    Fujita H; Utsumi T; Muranaka S; Ogino T; Yano H; Akiyama J; Yasuda T; Utsumi K
    Biochem Pharmacol; 2005 Jun; 69(12):1773-84. PubMed ID: 15869745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoprenoid-independent pathway is involved in apoptosis induced by risedronate, a bisphosphonate, in which Bim plays a critical role in breast cancer cell line MCF-7.
    Suyama K; Noguchi Y; Tanaka T; Yoshida T; Shibata T; Saito Y; Tatsuno I
    Oncol Rep; 2007 Nov; 18(5):1291-8. PubMed ID: 17914587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AG490, a Jak2-specific inhibitor, induces osteoclast survival by activating the Akt and ERK signaling pathways.
    Kwak HB; Sun HM; Ha H; Lee JH; Kim HN; Lee ZH
    Mol Cells; 2008 Nov; 26(5):436-42. PubMed ID: 18695355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative feedback loop in the Bim-caspase-3 axis regulating apoptosis and activity of osteoclasts.
    Wakeyama H; Akiyama T; Takahashi K; Amano H; Kadono Y; Nakamura M; Oshima Y; Itabe H; Nakayama KI; Nakayama K; Nakamura K; Tanaka S
    J Bone Miner Res; 2007 Oct; 22(10):1631-9. PubMed ID: 17592965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss.
    Kwak HB; Kim JY; Kim KJ; Choi MK; Kim JJ; Kim KM; Shin YI; Lee MS; Kim HS; Kim JW; Chun CH; Cho HJ; Hong GY; Juhng SK; Yoon KH; Park BH; Bae JM; Han JK; Oh J
    Biol Pharm Bull; 2009 Jul; 32(7):1193-8. PubMed ID: 19571384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
    Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
    J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1.
    Wang YF; Jiang CC; Kiejda KA; Gillespie S; Zhang XD; Hersey P
    Clin Cancer Res; 2007 Aug; 13(16):4934-42. PubMed ID: 17652623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway.
    Craxton A; Draves KE; Gruppi A; Clark EA
    J Exp Med; 2005 Nov; 202(10):1363-74. PubMed ID: 16301744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo.
    Hughes DE; Wright KR; Uy HL; Sasaki A; Yoneda T; Roodman GD; Mundy GR; Boyce BF
    J Bone Miner Res; 1995 Oct; 10(10):1478-87. PubMed ID: 8686503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proapoptotic Bcl-2 family member Bim plays a central role during the development of virus-induced hepatitis.
    Lauer C; Brunner T; Corazza N
    J Immunol; 2012 Jan; 188(2):916-22. PubMed ID: 22156338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim.
    Akiyama T; Bouillet P; Miyazaki T; Kadono Y; Chikuda H; Chung UI; Fukuda A; Hikita A; Seto H; Okada T; Inaba T; Sanjay A; Baron R; Kawaguchi H; Oda H; Nakamura K; Strasser A; Tanaka S
    EMBO J; 2003 Dec; 22(24):6653-64. PubMed ID: 14657036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose risedronate sodium protects bone cells after abrupt oestrogen withdrawal.
    Wang G; Zhu Z; Lei C; Li M; Liu F; Mao Y; Yu Z; Liu M; Zhao X; Tang T
    J Int Med Res; 2012; 40(5):1761-74. PubMed ID: 23206458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrogen-containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and Bim-mediated activation of the intrinsic apoptotic pathway.
    Tsubaki M; Itoh T; Satou T; Imano M; Komai M; Ogawa N; Mukai J; Nishida S
    Biochem Pharmacol; 2013 Jan; 85(2):163-72. PubMed ID: 23085435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risedronate inhibits bone marrow mesenchymal stem cell adipogenesis and switches RANKL/OPG ratio to impair osteoclast differentiation.
    Jin J; Wang L; Wang XK; Lai PL; Huang MJ; Jin DD; Zhong ZM; Chen JT; Bai XC
    J Surg Res; 2013 Mar; 180(1):e21-9. PubMed ID: 22487394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells.
    Greenhough A; Wallam CA; Hicks DJ; Moorghen M; Williams AC; Paraskeva C
    Oncogene; 2010 Jun; 29(23):3398-410. PubMed ID: 20348947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis.
    Wojciechowski S; Tripathi P; Bourdeau T; Acero L; Grimes HL; Katz JD; Finkelman FD; Hildeman DA
    J Exp Med; 2007 Jul; 204(7):1665-75. PubMed ID: 17591857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEK/ERK-mediated phosphorylation of Bim is required to ensure survival of T and B lymphocytes during mitogenic stimulation.
    O'Reilly LA; Kruse EA; Puthalakath H; Kelly PN; Kaufmann T; Huang DC; Strasser A
    J Immunol; 2009 Jul; 183(1):261-9. PubMed ID: 19542438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia.
    Reynolds C; Roderick JE; LaBelle JL; Bird G; Mathieu R; Bodaar K; Colon D; Pyati U; Stevenson KE; Qi J; Harris M; Silverman LB; Sallan SE; Bradner JE; Neuberg DS; Look AT; Walensky LD; Kelliher MA; Gutierrez A
    Leukemia; 2014 Sep; 28(9):1819-27. PubMed ID: 24552990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bim regulates BCR-induced entry of B cells into the cell cycle.
    Craxton A; Draves KE; Clark EA
    Eur J Immunol; 2007 Oct; 37(10):2715-22. PubMed ID: 17705137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.